FDA Logo links to FDA home page
Center for Biologics Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Biologics Evaluation and Research
 HHS Logo links to Department of Health and Human Services website

FDA Home Page | CBER A-Z Index | CBER Search | Contact CBER | CBER Home Page

horizontal rule
CBER links to product areas Blood Vaccines Cellular/Gene Therapy Tissue Devices
CBER links Products Industry Healthcare Reading Room Meetings What's New
horizontal rule

Cellular, Tissue and Gene Therapies Advisory Committee
(Formerly Biological Response Modifiers Advisory Committee)

horizontal rule

May 20, 2005 Meeting

Date and Time:

The meeting will be held by teleconference on May 20, 2005; 2:00 p.m. to approximately 4:00 p.m.

Location:

5515 Security Lane, Room 1113, Rockville, MD 20723. This meeting will be held by teleconference. The public is welcome to attend the meeting at the above location. A speakerphone will be provided at the specified location for public participation in the meeting.

Contact Persons:

Gail Dapolito or Rosanna L. Harvey, 301-827-0314, or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 3014512389. Please call the Information Line for up-to-date information on this meeting.

Agenda:

The Committee will receive an update on individual research programs in the Division of Therapeutic Proteins, Center for Drug Evaluation and Research.

Oral Presentations:

Between approximately 3:00 and 4:00 p.m. oral presentations from the public will be scheduled. Those desiring to make formal oral presentations should notify the contact person before May 13, 2005.

Closed Committee Deliberations:

From approximately 4:00 to 4:30 p.m. the meeting will be closed to permit discussion where disclosure would constitute a clearly unwarranted invasion of personal privacy (5 U.S.C. 52b(c) (6)). The Committee will discuss a review of individual FDA research programs.

 

 
horizontal rule